News | June 05, 2014

Record-Breaking 2,874 Abstracts Submitted to ASTRO’s 56th Annual Meeting

June 5, 2014 — The American Society for Radiation Oncology (ASTRO) has garnered a record-breaking total of 2,874 abstracts submitted for selection for the 56th annual meeting: 1,681 studies are from researchers in the United States, followed by 575 studies from Asia [Japan (206), China (191), Korea (93), Taiwan (33), India (31), Hong Kong (8), Singapore (7), Philippines (3), Thailand (2) and Malaysia (1)]; 171 studies from Canada; 54 studies from Germany; and 31 studies from the United Kingdom. The scientific presentations will include up to four plenary papers, 360 oral presentations, 1,862 posters and 144 digital posters in more than 50 educational sessions and for 20 disease-site tracks and topics including radiation biology, radiation physics, palliative care, patient safety and patient-reported outcomes.

The 2014 annual meeting will be held Sept. 14-17, at San Francisco’s Moscone Center, and is expected to attract more than 11,000 attendees including oncologists from all disciplines, medical physicists, dosimetrists, radiation therapists, radiation oncology nurses and nurse practitioners, biologists, physician assistants, practice administrators, industry representatives and other healthcare professionals from around the world.

Led by ASTRO President Bruce G. Haffty, M.D., FASTRO, the theme of the 2014 meeting is “Targeting Cancer: Technology and Biology.” The Presidential Symposium, “Local-regional Management of Breast Cancer: A Changing Paradigm,” will feature Jay R. Harris, M.D., FASTRO, and Thomas A. Buchholz, M.D., FASTRO, to highlight recent practice-changing landmark studies and current developments in the local-regional management of breast cancer.

Three keynote speakers will address a range of topics including oncologic imaging, biology and targeting in oncology, and human error and safety concerns: 

  • Hedvig Hricak, M.D., Ph.D., chair, department of radiation oncology, Memorial Sloan Kettering Cancer Center;
  • Frank McCormick, Ph.D., FRS, director, University of California San Francisco Helen Diller Family Comprehensive Cancer Center; and
  • Sidney Dekker, Ph.D., professor, Safety Science Innovation Lab, Griffith University, Brisbane, Australia.


For more information: www.astro.org

Related Content

Merit Medical Completes Acquisition of Cianna Medical
News | Women's Health | November 14, 2018
Disposable device manufacturer Merit Medical Systems Inc. announced the closing of a definitive merger agreement to...
Videos | ASTRO | November 08, 2018
ITN Editor Dave Fornell took a tour of some of the most innovative technologies on display on the expo floor at the 
The Fujifilm FCT Embrace CT System displayed for the first time at ASTRO 2018.
360 Photos | 360 View Photos | November 07, 2018
Fujifilm's first FDA-cleared compu...
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for radiation therapy displayed for the first time since gaining FDA clearance in 2018. It was displayed at the American Society for Radiotherapy and Oncology (ASTRO) 2018 annual meeting. Read more about this system at ASTRO 2018. #ASTRO18 #ASTRO2018
360 Photos | 360 View Photos | November 07, 2018
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for...
GE Healthcare Discovery RF Gen 2 system displayed at ASTRO 2018. It is a dedicated computed tomography (CT) scanner for radiation oncology
360 Photos | 360 View Photos | November 07, 2018
This is the GE Healthcare Discovery RF Gen 2 system displayed at the ...
Proton Therapy for Pediatric Brain Tumors Has Favorable Cognitive Outcomes
News | Proton Therapy | November 06, 2018
Proton therapy treatment for pediatric brain tumor patients is associated with better neurocognitive outcomes compared...
The patient’s wife changes the Optune array. Clinical trials indicate that the electrical fields emitted by Optune have the potential to lengthen the lives of patients with glioblastoma.

The patient’s wife changes the Optune array. Clinical trials indicate that the electrical fields emitted by Optune have the potential to lengthen the lives of patients with glioblastoma.

Feature | Radiation Oncology | November 06, 2018 | By Greg Freiherr
Approximately 11,000 professionals attended the four-day meeting of the...